| Market Cap | ₹40Cr |
| ROE | 3.48% |
| P/E Ratio(TTM) | 41.59 |
| EPS(TTM) | 0.37 |
| P/B Ratio | 0.98 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.10 |
| Book Value | 15.76 |
| Debt to Equity | 0.23 |
| Face Value | 10 |
| Parent Organisation | Dipna Pharmachem Ltd |
| Managing Director | Keyur Dipakkumar Shah |
| Founded | 2011 |
| BSE Symbol | 543594 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.42 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.89 | ||
| Wockhardt | NA (0.00%) | -459.97 | ||
| Cohance Lifesciences | NA (0.00%) | 65.93 |